➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Boehringer Ingelheim
Johnson and Johnson
Baxter
AstraZeneca

Last Updated: April 17, 2021

DrugPatentWatch Database Preview

Litigation Details for CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-05-23 1 Complaint and lawfully issued United States Patent No. 9,200,088 (“the ’088 patent”), entitled “Sulfoalkyl Ether … COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 9,200,088 26. CyDex realleges and incorporates…and interest in the ’088 patent and the ’582 patent (collectively, “the patents-in-suit”). … 1. This is an action for patent infringement under the patent laws of the United States arising…. This is an action for patent infringement arising under the Patent Laws of the United States, External link to document
2020-11-01 122 Opinion - Memorandum Opinion infringement of an additional patent, U.S. Patent No. 8,410,077 (the 077 patent”) (D.I. 41 Ex. C). (See generally…of U.S. Patent Nos. 9,200,088 (the “088 patent”) (D.I. 1 Ex. A); and 9,493,5 82 (the “582 patent”) (D.I…. “It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent.” fd. at 1321 (internal quotation marks omitted). The patent “specification is….” (582 patent at 6:19-34) The Court’s construction | This term appears in the 088 patent at claims External link to document
2020-01-29 39 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,410,077 B2 (First Amended Complaint… 23 May 2019 1:19-cv-00956 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Mallinckrodt
McKinsey
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.